Concepedia

Robert Jordan

RJ

Statistics

Publications

137

Citations

15.5K

H-Index

52

Active since

1951

Affiliations

Siga Technologies (United States)(Current)

Camp Quality New Jersey

New Jersey Department of Health

Centers for Disease Control and Prevention

Rutgers, The State University of New Jersey

Robert Jordan is an author at Siga Technologies (United States) specializing in infectious diseases, virology, and life sciences.

ORCID

Publications per year

1951–2023

137

Publications

137

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

, , +12

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

, , +17

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini, Erica L. Andres, Amy Sims et al. · mBio · 2018 · 1.5K citations · Full text

, , +16

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Emmie de Wit, Friederike Feldmann, Jacqueline Cronin et al. · Proceedings of the National Academy of Sciences · 2020 · 946 citations · Full text

, , +17

1–5 of 137